| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.28 | 8e-14 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-06 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-06 |